Nucleoside and nucleotide reverse transcriptase inhibitors
Bictegravir, Emtricitabine and Tenofovir Alafenamide
The FDA lists this product in 10 strengths and forms.
Composition
- Active ingredients
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 15MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 30MG · TabletANDA216914-004 · Tentative approval
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 200MG · TabletANDA216914-002 · Tentative approval
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 120MG · TabletANDA216914-005 · Tentative approval
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 25MG · TabletANDA216914-003 · Tentative approval
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 15MG · TabletThis page
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 120MG · TabletANDA218766-005 · Tentative approval
- BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 25MG · Tablet